NCT01866319
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
Not specified
Clinical trial condition
Melanoma
Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.
1,012 public trials
175 recruiting studies
Melanoma trial results
Completed
A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
NCT01897116
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT01682213
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT02545075
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Local Institution Nanjing, Jiangsu, China
- Local Institution Changchun, Jilin, China
- Local Institution Xi’an, Shanxi, China
- Local Institution Tianjin, Tianjin Municipality, China
Completed
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
NCT02223052
- Conditions
- Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
- Locations
-
- Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
- Mayo Clinic - Arizona Scottsdale, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- University of Iowa Iowa City, Iowa, United States
Completed
Spanish Registry of Mohs Surgery
NCT02310503
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, +24 more
- Locations
-
- Hospital Universitario de Cruces Barakaldo, Spain
- Hospital del Mar Barcelona, Spain
- Hospital Quirón Teknon Barcelona, Spain
- Hospital Santa Creu i Sant Pau Barcelona, Spain
NCT02516527
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Local Institution Guangzhou, Guangdong, China
NCT02431572
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +21 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
Completed
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
NCT01916135
- Conditions
- Carcinoma, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors
NCT02285101
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- California Cancer Associates for Research and Excellence, cCARE San Diego, California, United States
- John Wayne Cancer Institute Santa Monica, California, United States